We are live on
!
Find out more
LENZ
LENZ Therapeutics
LENZ
LENZ
145 hedge funds and large institutions have $303M invested in LENZ Therapeutics in 2026 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 56 increasing their positions, 28 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 28
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
6.39% less ownership
Funds ownership: 112.08% → 105.69% (-6.4%)
9% less funds holding
Funds holding: 160 → 145 (-15)
23% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 47
46% less capital invested
Capital invested by funds: $562M → $303M (-$258M)
54% less call options, than puts
Call options by funds: $1.1M | Put options by funds: $2.41M
Holders
145
Holders Change
-15
Holders Change %
-9.38%
% of All Funds
1.79%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
36
Increased
56
Reduced
28
Closed
47
Calls
$1.1M
Puts
$2.41M
Net Calls
-$1.31M
Net Calls Change
+$1.22M
Top Buyers
| 1 |
Squarepoint
New York
|
+$14.3M |
| 2 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$9.37M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$6.08M |
| 4 |
Morgan Stanley
New York
|
+$5.84M |
| 5 |
BOCH
Blue Owl Capital Holdings
New York
|
+$5.01M |
